"Investing in innovation is key to the success of Reliant Technologies and it is imperative that Reliant protect the value of its inventions," said Eric Stang, president and CEO of Reliant Technologies. "By forming this FTOPP in conjunction with Palomar and MGH, we are making it possible for companies to access and take advantage of fundamental intellectual property in the fractional space."
"Palomar is recognized as a technology leader with one of the strongest intellectual property portfolios and patent enforcement strategies in the industry," said Joe Caruso, president and CEO of Palomar Medical Technologies. "The FTOPP presents a compelling collection of intellectual property assets that are necessary to operate in the fractional space. We believe companies exploiting fractional technology will find it in their interest to take an FTOPP license and not risk the consequences of infringing such a large number of patents."
The FTOPP comprises six patent families, including eleven issued and
pending U.S. patents and applications, along with foreign counterparts.
Included in the FTOPP from Reliant are: U.S. patent numbers 6,632,219 and
6,059,820 and patent application number 11/250,139 (the "Tankovich-Baranov"
patent family named for early inventors in the fractional space Dr. Nikolai
Tankovich and Dr. Eugene Baranov); U.S. patent application number
10/542,390 (the "1678" patent family licensed by Reliant from MGH); and
U.S. patent application number 10/367,582 (the "582" patent family).
Included in the FTOPP from Palomar Medical Technologies are: U.S. patent
number 6,997,923 and patent application number 11/235,697 (the "923" patent
family -- jointly owned with and licens
'/>"/>
| SOURCE Reliant Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved |